BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25923053)

  • 21. Classification of follicular thyroid tumors by molecular signature: results of gene profiling.
    Barden CB; Shister KW; Zhu B; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ
    Clin Cancer Res; 2003 May; 9(5):1792-800. PubMed ID: 12738736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis.
    Chai YJ; Kim YA; Jee HG; Yi JW; Jang BG; Lee KE; Park YJ; Youn YK
    Surgery; 2014 Dec; 156(6):1559-67; discussion 1567-8. PubMed ID: 25456955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules.
    Finley DJ; Arora N; Zhu B; Gallagher L; Fahey TJ
    J Clin Endocrinol Metab; 2004 Jul; 89(7):3214-23. PubMed ID: 15240595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
    Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
    J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
    Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D
    APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
    Bizzarro T; Martini M; Capodimonti S; Straccia P; Lombardi CP; Pontecorvi A; Larocca LM; Rossi ED
    Cancer Cytopathol; 2016 Oct; 124(10):699-710. PubMed ID: 27717284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of borderline thyroid tumors by gene expression array analysis.
    Arora N; Scognamiglio T; Lubitz CC; Moo TA; Kato MA; Zhu B; Zarnegar R; Chen YT; Fahey TJ
    Cancer; 2009 Dec; 115(23):5421-31. PubMed ID: 19658182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular-derived neoplasms: morphometric and genetic differences.
    Proietti A; Sartori C; Borrelli N; Giannini R; Materazzi G; Leocata P; Elisei R; Vitti P; Miccoli P; Basolo F
    J Endocrinol Invest; 2013 Dec; 36(11):1055-61. PubMed ID: 23888303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis.
    Giordano TJ; Kuick R; Thomas DG; Misek DE; Vinco M; Sanders D; Zhu Z; Ciampi R; Roh M; Shedden K; Gauger P; Doherty G; Thompson NW; Hanash S; Koenig RJ; Nikiforov YE
    Oncogene; 2005 Oct; 24(44):6646-56. PubMed ID: 16007166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography.
    Chai YJ; Kim SJ; Kim SC; Koo do H; Min HS; Lee KE; Kim JH; Youn YK
    Clin Endocrinol (Oxf); 2014 Sep; 81(3):432-9. PubMed ID: 24548081
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genes differentially expressed in thyroid carcinoma identified by comparison of SAGE expression profiles.
    Pauws E; Veenboer GJ; Smit JW; de Vijlder JJ; Morreau H; Ris-Stalpers C
    FASEB J; 2004 Mar; 18(3):560-1. PubMed ID: 14715705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential gene expression profiling of aggressive and nonaggressive follicular carcinomas.
    Williams MD; Zhang L; Elliott DD; Perrier ND; Lozano G; Clayman GL; El-Naggar AK
    Hum Pathol; 2011 Sep; 42(9):1213-20. PubMed ID: 21420716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of CD56 immunohistochemistry in thyroid lesions.
    Pyo JS; Kim DH; Yang J
    Int J Biol Markers; 2018 May; 33(2):161-167. PubMed ID: 29799356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular analysis of minimally invasive follicular carcinomas by gene profiling.
    Lubitz CC; Gallagher LA; Finley DJ; Zhu B; Fahey TJ
    Surgery; 2005 Dec; 138(6):1042-8; discussion 1048-9. PubMed ID: 16360389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
    Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA microarray and miRNA analyses reinforce the classification of follicular thyroid tumors.
    Jacques C; Guillotin D; Fontaine JF; Franc B; Mirebeau-Prunier D; Fleury A; Malthiery Y; Savagner F
    J Clin Endocrinol Metab; 2013 May; 98(5):E981-9. PubMed ID: 23569218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in miRNA expression profiles between wild-type and mutated NIFTPs.
    Denaro M; Ugolini C; Poma AM; Borrelli N; Materazzi G; Piaggi P; Chiarugi M; Miccoli P; Vitti P; Basolo F
    Endocr Relat Cancer; 2017 Oct; 24(10):543-553. PubMed ID: 28830935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene profiling identifies genes specific for well-differentiated epithelial thyroid tumors.
    Puskas LG; Juhasz F; Zarva A; Hackler L; Farid NR
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):177-86. PubMed ID: 16171553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.